Prolight Diagnostics

Prolight Diagnostics Fondo · SE0003618230 (XSTO) — cotizaciones en tiempo real, datos de la empresa, dividendos, fundamentales y análisis de cartera con IA en MoneyPeak

Resumen
Análisis impulsado por IA
Análisis fundamental
Descubre lo que realmente dicen los números — antes que el mercado
Analizar ahora
Sentimiento de noticias
¿Las noticias de hoy son una señal de compra o una alerta?
Analizar ahora
Comprar / Mantener / Vender
¿Comprar, mantener o vender? Obtén el veredicto de la IA ahora.
Analizar ahora
Evaluación de riesgos
Descubre riesgos ocultos antes de que afecten a tu cartera.
Analizar ahora
Valor justo
¿Esta acción está barata, correctamente valorada o sobrevalorada?
Analizar ahora
Latest AI Analyses of Prolight Diagnostics
No Price
Share Float & Liquidity
Free Float -
Shares Float -
Shares Outstanding 12,04 M
Company Profile for Prolight Diagnostics Fund
Prolight Diagnostics AB develops patient-based test systems based on patented technology. It offers integrated diagnostic support consisting of handy measuring instruments and disposable chips for diagnosis of heart attacks and also for long-term evaluation of the risks for heart disease. The company was founded by Masoud Khayyami in 1999 and is headquartered in Lund, Sweden.

Company Data

Name Prolight Diagnostics
Company Prolight Diagnostics
Website http://www.pldab.com
Primary Exchange XSTO NASDAQ STOCKHOLM AB
ISIN SE0003618230
Asset Class Fund
Sector Healthcare
Industry Medical - Specialties
CEO Ulf Bladin
Country Sweden
Currency SEK
Employees -
Address , Lund
IPO Date 2017-03-31

Stock Splits

Date Split
10.12.2025 1:100

Ticker Symbols

Name Symbol
NASDAQ STOCKHOLM AB PRLD.ST
More Shares
Investors who hold Prolight Diagnostics also have the following shares in their portfolio:
AMOEBA            EO -,02
AMOEBA EO -,02 Share
TCW Conservative Allocation Fund Cl N
TCW Conservative Allocation Fund Cl N Fund